foto
VIEW OUR WEB SEMINARS
LATEST NEWS

OctoPlus announces successful equity raising of € 4 million



HALF-YEAR RESULTS: 6 AUGUST

Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET



ANNUAL REPORT 2008

Click here to directly access OctoPlus' Annual Report 2008



GMP EXPANSION

OctoPlus has increased its fill & finish capacity by expanding its GMP facility



OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

PHARMACEUTICAL INNOVATORS

OctoPlus is a product-oriented drug delivery company focused on the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world.

Our business activities include formulation development services, drug delivery technologies and controlled release product development. Please use the menu to learn more about our activities.